Literature DB >> 9648790

Prostatic cancer: role of color Doppler imaging in transrectal sonography.

A M Lavoipierre1, R M Snow, M Frydenberg, D Gunter, G Reisner, P L Royce, G J Lavoipierre.   

Abstract

OBJECTIVE: The aim of this study was to assess the roles of transrectal color Doppler and gray-scale sonography in revealing prostatic cancer, using biopsy as the reference standard. SUBJECTS AND METHODS: Two hundred fifty-six patients referred for urologic studies underwent transrectal sonography using gray-scale and color Doppler scanning. All abnormal areas shown on gray-scale or color Doppler sonography or both were targeted and biopsies were performed. The patients also underwent random sextant biopsies. All biopsies were individually correlated with histopathologic findings and all results were analyzed.
RESULTS: Cancer was found on biopsy in 100 patients (39%), and equivocal sonographic results or prostatic intraepithelial neoplasia was found in 22 other patients (9%). In 16 of the patients in whom cancer was detected, the tumors were correctly revealed only with color Doppler sonography. These 16 patients had a mean Gleason score of 6.4 (range, 5-8). Biopsy findings in these 16 patients showed eight patients with extensive lesions, three with moderate lesions, and five with minimal lesions. However, in nine other patients with cancer (9% of cancers detected), both gray-scale and color Doppler sonography failed to reveal lesions that were found on sextant biopsy. An analysis showed that, although highly sensitive, color Doppler sonography was somewhat less specific than gray-scale sonography.
CONCLUSION: Color Doppler sonography should become a routine part of transrectal sonography of the prostate gland to improve detection and targeting of lesions. The practice of performing random sextant biopsies should also continue.

Entities:  

Mesh:

Year:  1998        PMID: 9648790     DOI: 10.2214/ajr.171.1.9648790

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

2.  [The impact of ultrasound in urology].

Authors:  G Schöppler; J Heinzelbecker; H J Michaely; D Dinter; D-A Clevert; A E Pelzer
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

Review 3.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 4.  [Imaging modalities for primary diagnosis and staging of prostate cancer].

Authors:  U G Mueller-Lisse; K Miller
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

5.  Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results.

Authors:  H-X Zhao; Q Zhu; Z-C Wang
Journal:  Br J Radiol       Date:  2011-06-28       Impact factor: 3.039

Review 6.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

7.  Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.

Authors:  Masahiko Inahara; Hiroyoshi Suzuki; Hiroshi Nakamachi; Naoto Kamiya; Masaki Shimbo; Akira Komiya; Takeshi Ueda; Tomohiko Ichikawa; Koichiro Akakura; Haruo Ito
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 8.  The role of transrectal ultrasound in diagnosing prostate cancer.

Authors:  Richard Clements
Journal:  Curr Urol Rep       Date:  2002-06       Impact factor: 2.862

9.  Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer.

Authors:  Ho Yun Lee; Hak Jong Lee; Seok-Soo Byun; Sang Eun Lee; Sung Kyu Hong; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2009-04-22       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.